China Reform (China) Performance
| 000503 Stock | 10.09 0.13 1.31% |
China Reform has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.39, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, China Reform's returns are expected to increase less than the market. However, during the bear market, the loss of holding China Reform is expected to be smaller as well. China Reform Health right now shows a risk of 4.7%. Please confirm China Reform Health semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation , to decide if China Reform Health will be following its price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in China Reform Health are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, China Reform may actually be approaching a critical reversion point that can send shares even higher in February 2025. ...more
Last Split Factor 12:10 | Ex Dividend Date 2004-05-31 | Last Split Date 2011-06-10 |
1 | Chinas financial reforms an invitation for foreign firms to boost growth BOC chairman - Yahoo Finance | 10/22/2024 |
2 | China Stocks Rise on Reform Hopes, Steady Interest Rates - Marketscreener.com | 11/19/2024 |
| Begin Period Cash Flow | 161.4 M |
China |
China Reform Relative Risk vs. Return Landscape
If you would invest 1,002 in China Reform Health on October 10, 2024 and sell it today you would earn a total of 7.00 from holding China Reform Health or generate 0.7% return on investment over 90 days. China Reform Health is generating 0.1178% of daily returns and assumes 4.7031% volatility on return distribution over the 90 days horizon. Simply put, 41% of stocks are less volatile than China, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
China Reform Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for China Reform's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as China Reform Health, and traders can use it to determine the average amount a China Reform's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.025
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | 000503 | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.7 actual daily | 41 59% of assets are more volatile |
Expected Return
| 0.12 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 1 99% of assets perform better |
Based on monthly moving average China Reform is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of China Reform by adding it to a well-diversified portfolio.
China Reform Fundamentals Growth
China Stock prices reflect investors' perceptions of the future prospects and financial health of China Reform, and China Reform fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on China Stock performance.
| Return On Equity | -0.0038 | ||||
| Return On Asset | -0.0499 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | (0.50) % | ||||
| Current Valuation | 8.85 B | ||||
| Shares Outstanding | 981.31 M | ||||
| Price To Book | 7.13 X | ||||
| Price To Sales | 26.65 X | ||||
| Revenue | 330.13 M | ||||
| Gross Profit | 64.46 M | ||||
| EBITDA | (87.35 M) | ||||
| Net Income | (79.79 M) | ||||
| Total Debt | 193.94 M | ||||
| Book Value Per Share | 1.42 X | ||||
| Cash Flow From Operations | (102.22 M) | ||||
| Total Asset | 1.95 B | ||||
| Retained Earnings | (163.05 M) | ||||
About China Reform Performance
By analyzing China Reform's fundamental ratios, stakeholders can gain valuable insights into China Reform's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if China Reform has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if China Reform has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
China Reform is entity of China. It is traded as Stock on SHE exchange.Things to note about China Reform Health performance evaluation
Checking the ongoing alerts about China Reform for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for China Reform Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| China Reform Health had very high historical volatility over the last 90 days | |
| The company reported the revenue of 330.13 M. Net Loss for the year was (79.79 M) with profit before overhead, payroll, taxes, and interest of 64.46 M. | |
| China Reform generates negative cash flow from operations | |
| About 29.0% of the company shares are owned by insiders or employees |
- Analyzing China Reform's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether China Reform's stock is overvalued or undervalued compared to its peers.
- Examining China Reform's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating China Reform's management team can have a significant impact on its success or failure. Reviewing the track record and experience of China Reform's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of China Reform's stock. These opinions can provide insight into China Reform's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for China Stock analysis
When running China Reform's price analysis, check to measure China Reform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Reform is operating at the current time. Most of China Reform's value examination focuses on studying past and present price action to predict the probability of China Reform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Reform's price. Additionally, you may evaluate how the addition of China Reform to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |